Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
22
LEG Quote, Financials, Valuation and Earnings
Last price:
$8.22
Seasonality move
:
3.79%
Day range:
$8.03 - $8.28
52-week range:
$7.92 - $19.33
Dividend yield:
2.43%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
1.61x
Volume:
21M
Avg. volume:
3M
1-year change:
-56.58%
Market cap:
$1.1B
Revenue:
$4.4B
EPS (TTM):
-$3.73
Leggett & Platt Number of Institutional Trades
Leggett & Platt Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$1.5B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$3.9B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Leggett & Platt Institutional Ownership
-
What Percentage Of LEG Is Owned by Institutions?
-- of LEG is owned by institutions.
-
How Many Institutions Own LEG Shares?
Leggett & Platt stock is owned by 697 institutional shareholders at this time.
-
Have Institutions Been Buying LEG Stock?
Yes, institutions have bought 59.4M shares of LEG in the last quarter.
-
Have Institutions Been Selling LEG Stock?
Yes, institutions have sold 184.8M shares of LEG over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
